Global Chronic Pain Management Drugs Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Page: 102

Published Date: 08 Jan 2025

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Chronic Pain Management Drugs market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report is a detailed and comprehensive analysis for global Chronic Pain Management Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:
Global Chronic Pain Management Drugs market size and forecasts, in consumption value ($ Million), 2020-2031
Global Chronic Pain Management Drugs market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Chronic Pain Management Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Chronic Pain Management Drugs market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Chronic Pain Management Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Chronic Pain Management Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer Inc., Depomed Inc., Endo International plc., Purdue Pharma L.P., Novartis AG, AstraZeneca plc., Johnson and Johnson Services Inc., Merck & Co., Abbott Laboratories, GlaxoSmithKline plc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
Chronic Pain Management Drugs market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Opioids
Non-narcotic Analgesic
Others

Market segment by Application
Hospital
Clinic
Others

Market segment by players, this report covers
Pfizer Inc.
Depomed Inc.
Endo International plc.
Purdue Pharma L.P.
Novartis AG
AstraZeneca plc.
Johnson and Johnson Services Inc.
Merck & Co.
Abbott Laboratories
GlaxoSmithKline plc.
Teva Pharmaceutical Industries Ltd.

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Chronic Pain Management Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Chronic Pain Management Drugs, with revenue, gross margin, and global market share of Chronic Pain Management Drugs from 2020 to 2025.
Chapter 3, the Chronic Pain Management Drugs competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Chronic Pain Management Drugs market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Chronic Pain Management Drugs.
Chapter 13, to describe Chronic Pain Management Drugs research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Chronic Pain Management Drugs by Type
        1.3.1 Overview: Global Chronic Pain Management Drugs Market Size by Type: 2020 Versus 2024 Versus 2031
        1.3.2 Global Chronic Pain Management Drugs Consumption Value Market Share by Type in 2024
        1.3.3 Opioids
        1.3.4 Non-narcotic Analgesic
        1.3.5 Others
    1.4 Global Chronic Pain Management Drugs Market by Application
        1.4.1 Overview: Global Chronic Pain Management Drugs Market Size by Application: 2020 Versus 2024 Versus 2031
        1.4.2 Hospital
        1.4.3 Clinic
        1.4.4 Others
    1.5 Global Chronic Pain Management Drugs Market Size & Forecast
    1.6 Global Chronic Pain Management Drugs Market Size and Forecast by Region
        1.6.1 Global Chronic Pain Management Drugs Market Size by Region: 2020 VS 2024 VS 2031
        1.6.2 Global Chronic Pain Management Drugs Market Size by Region, (2020-2031)
        1.6.3 North America Chronic Pain Management Drugs Market Size and Prospect (2020-2031)
        1.6.4 Europe Chronic Pain Management Drugs Market Size and Prospect (2020-2031)
        1.6.5 Asia-Pacific Chronic Pain Management Drugs Market Size and Prospect (2020-2031)
        1.6.6 South America Chronic Pain Management Drugs Market Size and Prospect (2020-2031)
        1.6.7 Middle East & Africa Chronic Pain Management Drugs Market Size and Prospect (2020-2031)

2 Company Profiles
    2.1 Pfizer Inc.
        2.1.1 Pfizer Inc. Details
        2.1.2 Pfizer Inc. Major Business
        2.1.3 Pfizer Inc. Chronic Pain Management Drugs Product and Solutions
        2.1.4 Pfizer Inc. Chronic Pain Management Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.1.5 Pfizer Inc. Recent Developments and Future Plans
    2.2 Depomed Inc.
        2.2.1 Depomed Inc. Details
        2.2.2 Depomed Inc. Major Business
        2.2.3 Depomed Inc. Chronic Pain Management Drugs Product and Solutions
        2.2.4 Depomed Inc. Chronic Pain Management Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.2.5 Depomed Inc. Recent Developments and Future Plans
    2.3 Endo International plc.
        2.3.1 Endo International plc. Details
        2.3.2 Endo International plc. Major Business
        2.3.3 Endo International plc. Chronic Pain Management Drugs Product and Solutions
        2.3.4 Endo International plc. Chronic Pain Management Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.3.5 Endo International plc. Recent Developments and Future Plans
    2.4 Purdue Pharma L.P.
        2.4.1 Purdue Pharma L.P. Details
        2.4.2 Purdue Pharma L.P. Major Business
        2.4.3 Purdue Pharma L.P. Chronic Pain Management Drugs Product and Solutions
        2.4.4 Purdue Pharma L.P. Chronic Pain Management Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.4.5 Purdue Pharma L.P. Recent Developments and Future Plans
    2.5 Novartis AG
        2.5.1 Novartis AG Details
        2.5.2 Novartis AG Major Business
        2.5.3 Novartis AG Chronic Pain Management Drugs Product and Solutions
        2.5.4 Novartis AG Chronic Pain Management Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.5.5 Novartis AG Recent Developments and Future Plans
    2.6 AstraZeneca plc.
        2.6.1 AstraZeneca plc. Details
        2.6.2 AstraZeneca plc. Major Business
        2.6.3 AstraZeneca plc. Chronic Pain Management Drugs Product and Solutions
        2.6.4 AstraZeneca plc. Chronic Pain Management Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.6.5 AstraZeneca plc. Recent Developments and Future Plans
    2.7 Johnson and Johnson Services Inc.
        2.7.1 Johnson and Johnson Services Inc. Details
        2.7.2 Johnson and Johnson Services Inc. Major Business
        2.7.3 Johnson and Johnson Services Inc. Chronic Pain Management Drugs Product and Solutions
        2.7.4 Johnson and Johnson Services Inc. Chronic Pain Management Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.7.5 Johnson and Johnson Services Inc. Recent Developments and Future Plans
    2.8 Merck & Co.
        2.8.1 Merck & Co. Details
        2.8.2 Merck & Co. Major Business
        2.8.3 Merck & Co. Chronic Pain Management Drugs Product and Solutions
        2.8.4 Merck & Co. Chronic Pain Management Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.8.5 Merck & Co. Recent Developments and Future Plans
    2.9 Abbott Laboratories
        2.9.1 Abbott Laboratories Details
        2.9.2 Abbott Laboratories Major Business
        2.9.3 Abbott Laboratories Chronic Pain Management Drugs Product and Solutions
        2.9.4 Abbott Laboratories Chronic Pain Management Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.9.5 Abbott Laboratories Recent Developments and Future Plans
    2.10 GlaxoSmithKline plc.
        2.10.1 GlaxoSmithKline plc. Details
        2.10.2 GlaxoSmithKline plc. Major Business
        2.10.3 GlaxoSmithKline plc. Chronic Pain Management Drugs Product and Solutions
        2.10.4 GlaxoSmithKline plc. Chronic Pain Management Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.10.5 GlaxoSmithKline plc. Recent Developments and Future Plans
    2.11 Teva Pharmaceutical Industries Ltd.
        2.11.1 Teva Pharmaceutical Industries Ltd. Details
        2.11.2 Teva Pharmaceutical Industries Ltd. Major Business
        2.11.3 Teva Pharmaceutical Industries Ltd. Chronic Pain Management Drugs Product and Solutions
        2.11.4 Teva Pharmaceutical Industries Ltd. Chronic Pain Management Drugs Revenue, Gross Margin and Market Share (2020-2025)
        2.11.5 Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Chronic Pain Management Drugs Revenue and Share by Players (2020-2025)
    3.2 Market Share Analysis (2024)
        3.2.1 Market Share of Chronic Pain Management Drugs by Company Revenue
        3.2.2 Top 3 Chronic Pain Management Drugs Players Market Share in 2024
        3.2.3 Top 6 Chronic Pain Management Drugs Players Market Share in 2024
    3.3 Chronic Pain Management Drugs Market: Overall Company Footprint Analysis
        3.3.1 Chronic Pain Management Drugs Market: Region Footprint
        3.3.2 Chronic Pain Management Drugs Market: Company Product Type Footprint
        3.3.3 Chronic Pain Management Drugs Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Chronic Pain Management Drugs Consumption Value and Market Share by Type (2020-2025)
    4.2 Global Chronic Pain Management Drugs Market Forecast by Type (2026-2031)

5 Market Size Segment by Application
    5.1 Global Chronic Pain Management Drugs Consumption Value Market Share by Application (2020-2025)
    5.2 Global Chronic Pain Management Drugs Market Forecast by Application (2026-2031)

6 North America
    6.1 North America Chronic Pain Management Drugs Consumption Value by Type (2020-2031)
    6.2 North America Chronic Pain Management Drugs Market Size by Application (2020-2031)
    6.3 North America Chronic Pain Management Drugs Market Size by Country
        6.3.1 North America Chronic Pain Management Drugs Consumption Value by Country (2020-2031)
        6.3.2 United States Chronic Pain Management Drugs Market Size and Forecast (2020-2031)
        6.3.3 Canada Chronic Pain Management Drugs Market Size and Forecast (2020-2031)
        6.3.4 Mexico Chronic Pain Management Drugs Market Size and Forecast (2020-2031)

7 Europe
    7.1 Europe Chronic Pain Management Drugs Consumption Value by Type (2020-2031)
    7.2 Europe Chronic Pain Management Drugs Consumption Value by Application (2020-2031)
    7.3 Europe Chronic Pain Management Drugs Market Size by Country
        7.3.1 Europe Chronic Pain Management Drugs Consumption Value by Country (2020-2031)
        7.3.2 Germany Chronic Pain Management Drugs Market Size and Forecast (2020-2031)
        7.3.3 France Chronic Pain Management Drugs Market Size and Forecast (2020-2031)
        7.3.4 United Kingdom Chronic Pain Management Drugs Market Size and Forecast (2020-2031)
        7.3.5 Russia Chronic Pain Management Drugs Market Size and Forecast (2020-2031)
        7.3.6 Italy Chronic Pain Management Drugs Market Size and Forecast (2020-2031)

8 Asia-Pacific
    8.1 Asia-Pacific Chronic Pain Management Drugs Consumption Value by Type (2020-2031)
    8.2 Asia-Pacific Chronic Pain Management Drugs Consumption Value by Application (2020-2031)
    8.3 Asia-Pacific Chronic Pain Management Drugs Market Size by Region
        8.3.1 Asia-Pacific Chronic Pain Management Drugs Consumption Value by Region (2020-2031)
        8.3.2 China Chronic Pain Management Drugs Market Size and Forecast (2020-2031)
        8.3.3 Japan Chronic Pain Management Drugs Market Size and Forecast (2020-2031)
        8.3.4 South Korea Chronic Pain Management Drugs Market Size and Forecast (2020-2031)
        8.3.5 India Chronic Pain Management Drugs Market Size and Forecast (2020-2031)
        8.3.6 Southeast Asia Chronic Pain Management Drugs Market Size and Forecast (2020-2031)
        8.3.7 Australia Chronic Pain Management Drugs Market Size and Forecast (2020-2031)

9 South America
    9.1 South America Chronic Pain Management Drugs Consumption Value by Type (2020-2031)
    9.2 South America Chronic Pain Management Drugs Consumption Value by Application (2020-2031)
    9.3 South America Chronic Pain Management Drugs Market Size by Country
        9.3.1 South America Chronic Pain Management Drugs Consumption Value by Country (2020-2031)
        9.3.2 Brazil Chronic Pain Management Drugs Market Size and Forecast (2020-2031)
        9.3.3 Argentina Chronic Pain Management Drugs Market Size and Forecast (2020-2031)

10 Middle East & Africa
    10.1 Middle East & Africa Chronic Pain Management Drugs Consumption Value by Type (2020-2031)
    10.2 Middle East & Africa Chronic Pain Management Drugs Consumption Value by Application (2020-2031)
    10.3 Middle East & Africa Chronic Pain Management Drugs Market Size by Country
        10.3.1 Middle East & Africa Chronic Pain Management Drugs Consumption Value by Country (2020-2031)
        10.3.2 Turkey Chronic Pain Management Drugs Market Size and Forecast (2020-2031)
        10.3.3 Saudi Arabia Chronic Pain Management Drugs Market Size and Forecast (2020-2031)
        10.3.4 UAE Chronic Pain Management Drugs Market Size and Forecast (2020-2031)

11 Market Dynamics
    11.1 Chronic Pain Management Drugs Market Drivers
    11.2 Chronic Pain Management Drugs Market Restraints
    11.3 Chronic Pain Management Drugs Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Chronic Pain Management Drugs Industry Chain
    12.2 Chronic Pain Management Drugs Upstream Analysis
    12.3 Chronic Pain Management Drugs Midstream Analysis
    12.4 Chronic Pain Management Drugs Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Chronic Pain Management Drugs Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Table 2. Global Chronic Pain Management Drugs Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Table 3. Global Chronic Pain Management Drugs Consumption Value by Region (2020-2025) & (USD Million)
 Table 4. Global Chronic Pain Management Drugs Consumption Value by Region (2026-2031) & (USD Million)
 Table 5. Pfizer Inc. Company Information, Head Office, and Major Competitors
 Table 6. Pfizer Inc. Major Business
 Table 7. Pfizer Inc. Chronic Pain Management Drugs Product and Solutions
 Table 8. Pfizer Inc. Chronic Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 9. Pfizer Inc. Recent Developments and Future Plans
 Table 10. Depomed Inc. Company Information, Head Office, and Major Competitors
 Table 11. Depomed Inc. Major Business
 Table 12. Depomed Inc. Chronic Pain Management Drugs Product and Solutions
 Table 13. Depomed Inc. Chronic Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 14. Depomed Inc. Recent Developments and Future Plans
 Table 15. Endo International plc. Company Information, Head Office, and Major Competitors
 Table 16. Endo International plc. Major Business
 Table 17. Endo International plc. Chronic Pain Management Drugs Product and Solutions
 Table 18. Endo International plc. Chronic Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 19. Purdue Pharma L.P. Company Information, Head Office, and Major Competitors
 Table 20. Purdue Pharma L.P. Major Business
 Table 21. Purdue Pharma L.P. Chronic Pain Management Drugs Product and Solutions
 Table 22. Purdue Pharma L.P. Chronic Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 23. Purdue Pharma L.P. Recent Developments and Future Plans
 Table 24. Novartis AG Company Information, Head Office, and Major Competitors
 Table 25. Novartis AG Major Business
 Table 26. Novartis AG Chronic Pain Management Drugs Product and Solutions
 Table 27. Novartis AG Chronic Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 28. Novartis AG Recent Developments and Future Plans
 Table 29. AstraZeneca plc. Company Information, Head Office, and Major Competitors
 Table 30. AstraZeneca plc. Major Business
 Table 31. AstraZeneca plc. Chronic Pain Management Drugs Product and Solutions
 Table 32. AstraZeneca plc. Chronic Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 33. AstraZeneca plc. Recent Developments and Future Plans
 Table 34. Johnson and Johnson Services Inc. Company Information, Head Office, and Major Competitors
 Table 35. Johnson and Johnson Services Inc. Major Business
 Table 36. Johnson and Johnson Services Inc. Chronic Pain Management Drugs Product and Solutions
 Table 37. Johnson and Johnson Services Inc. Chronic Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 38. Johnson and Johnson Services Inc. Recent Developments and Future Plans
 Table 39. Merck & Co. Company Information, Head Office, and Major Competitors
 Table 40. Merck & Co. Major Business
 Table 41. Merck & Co. Chronic Pain Management Drugs Product and Solutions
 Table 42. Merck & Co. Chronic Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 43. Merck & Co. Recent Developments and Future Plans
 Table 44. Abbott Laboratories Company Information, Head Office, and Major Competitors
 Table 45. Abbott Laboratories Major Business
 Table 46. Abbott Laboratories Chronic Pain Management Drugs Product and Solutions
 Table 47. Abbott Laboratories Chronic Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 48. Abbott Laboratories Recent Developments and Future Plans
 Table 49. GlaxoSmithKline plc. Company Information, Head Office, and Major Competitors
 Table 50. GlaxoSmithKline plc. Major Business
 Table 51. GlaxoSmithKline plc. Chronic Pain Management Drugs Product and Solutions
 Table 52. GlaxoSmithKline plc. Chronic Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 53. GlaxoSmithKline plc. Recent Developments and Future Plans
 Table 54. Teva Pharmaceutical Industries Ltd. Company Information, Head Office, and Major Competitors
 Table 55. Teva Pharmaceutical Industries Ltd. Major Business
 Table 56. Teva Pharmaceutical Industries Ltd. Chronic Pain Management Drugs Product and Solutions
 Table 57. Teva Pharmaceutical Industries Ltd. Chronic Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 58. Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
 Table 59. Global Chronic Pain Management Drugs Revenue (USD Million) by Players (2020-2025)
 Table 60. Global Chronic Pain Management Drugs Revenue Share by Players (2020-2025)
 Table 61. Breakdown of Chronic Pain Management Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 62. Market Position of Players in Chronic Pain Management Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
 Table 63. Head Office of Key Chronic Pain Management Drugs Players
 Table 64. Chronic Pain Management Drugs Market: Company Product Type Footprint
 Table 65. Chronic Pain Management Drugs Market: Company Product Application Footprint
 Table 66. Chronic Pain Management Drugs New Market Entrants and Barriers to Market Entry
 Table 67. Chronic Pain Management Drugs Mergers, Acquisition, Agreements, and Collaborations
 Table 68. Global Chronic Pain Management Drugs Consumption Value (USD Million) by Type (2020-2025)
 Table 69. Global Chronic Pain Management Drugs Consumption Value Share by Type (2020-2025)
 Table 70. Global Chronic Pain Management Drugs Consumption Value Forecast by Type (2026-2031)
 Table 71. Global Chronic Pain Management Drugs Consumption Value by Application (2020-2025)
 Table 72. Global Chronic Pain Management Drugs Consumption Value Forecast by Application (2026-2031)
 Table 73. North America Chronic Pain Management Drugs Consumption Value by Type (2020-2025) & (USD Million)
 Table 74. North America Chronic Pain Management Drugs Consumption Value by Type (2026-2031) & (USD Million)
 Table 75. North America Chronic Pain Management Drugs Consumption Value by Application (2020-2025) & (USD Million)
 Table 76. North America Chronic Pain Management Drugs Consumption Value by Application (2026-2031) & (USD Million)
 Table 77. North America Chronic Pain Management Drugs Consumption Value by Country (2020-2025) & (USD Million)
 Table 78. North America Chronic Pain Management Drugs Consumption Value by Country (2026-2031) & (USD Million)
 Table 79. Europe Chronic Pain Management Drugs Consumption Value by Type (2020-2025) & (USD Million)
 Table 80. Europe Chronic Pain Management Drugs Consumption Value by Type (2026-2031) & (USD Million)
 Table 81. Europe Chronic Pain Management Drugs Consumption Value by Application (2020-2025) & (USD Million)
 Table 82. Europe Chronic Pain Management Drugs Consumption Value by Application (2026-2031) & (USD Million)
 Table 83. Europe Chronic Pain Management Drugs Consumption Value by Country (2020-2025) & (USD Million)
 Table 84. Europe Chronic Pain Management Drugs Consumption Value by Country (2026-2031) & (USD Million)
 Table 85. Asia-Pacific Chronic Pain Management Drugs Consumption Value by Type (2020-2025) & (USD Million)
 Table 86. Asia-Pacific Chronic Pain Management Drugs Consumption Value by Type (2026-2031) & (USD Million)
 Table 87. Asia-Pacific Chronic Pain Management Drugs Consumption Value by Application (2020-2025) & (USD Million)
 Table 88. Asia-Pacific Chronic Pain Management Drugs Consumption Value by Application (2026-2031) & (USD Million)
 Table 89. Asia-Pacific Chronic Pain Management Drugs Consumption Value by Region (2020-2025) & (USD Million)
 Table 90. Asia-Pacific Chronic Pain Management Drugs Consumption Value by Region (2026-2031) & (USD Million)
 Table 91. South America Chronic Pain Management Drugs Consumption Value by Type (2020-2025) & (USD Million)
 Table 92. South America Chronic Pain Management Drugs Consumption Value by Type (2026-2031) & (USD Million)
 Table 93. South America Chronic Pain Management Drugs Consumption Value by Application (2020-2025) & (USD Million)
 Table 94. South America Chronic Pain Management Drugs Consumption Value by Application (2026-2031) & (USD Million)
 Table 95. South America Chronic Pain Management Drugs Consumption Value by Country (2020-2025) & (USD Million)
 Table 96. South America Chronic Pain Management Drugs Consumption Value by Country (2026-2031) & (USD Million)
 Table 97. Middle East & Africa Chronic Pain Management Drugs Consumption Value by Type (2020-2025) & (USD Million)
 Table 98. Middle East & Africa Chronic Pain Management Drugs Consumption Value by Type (2026-2031) & (USD Million)
 Table 99. Middle East & Africa Chronic Pain Management Drugs Consumption Value by Application (2020-2025) & (USD Million)
 Table 100. Middle East & Africa Chronic Pain Management Drugs Consumption Value by Application (2026-2031) & (USD Million)
 Table 101. Middle East & Africa Chronic Pain Management Drugs Consumption Value by Country (2020-2025) & (USD Million)
 Table 102. Middle East & Africa Chronic Pain Management Drugs Consumption Value by Country (2026-2031) & (USD Million)
 Table 103. Global Key Players of Chronic Pain Management Drugs Upstream (Raw Materials)
 Table 104. Global Chronic Pain Management Drugs Typical Customers


List of Figures
 Figure 1. Chronic Pain Management Drugs Picture
 Figure 2. Global Chronic Pain Management Drugs Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Figure 3. Global Chronic Pain Management Drugs Consumption Value Market Share by Type in 2024
 Figure 4. Opioids
 Figure 5. Non-narcotic Analgesic
 Figure 6. Others
 Figure 7. Global Chronic Pain Management Drugs Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Figure 8. Chronic Pain Management Drugs Consumption Value Market Share by Application in 2024
 Figure 9. Hospital Picture
 Figure 10. Clinic Picture
 Figure 11. Others Picture
 Figure 12. Global Chronic Pain Management Drugs Consumption Value, (USD Million): 2020 & 2024 & 2031
 Figure 13. Global Chronic Pain Management Drugs Consumption Value and Forecast (2020-2031) & (USD Million)
 Figure 14. Global Market Chronic Pain Management Drugs Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
 Figure 15. Global Chronic Pain Management Drugs Consumption Value Market Share by Region (2020-2031)
 Figure 16. Global Chronic Pain Management Drugs Consumption Value Market Share by Region in 2024
 Figure 17. North America Chronic Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 18. Europe Chronic Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 19. Asia-Pacific Chronic Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 20. South America Chronic Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 21. Middle East & Africa Chronic Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 22. Company Three Recent Developments and Future Plans
 Figure 23. Global Chronic Pain Management Drugs Revenue Share by Players in 2024
 Figure 24. Chronic Pain Management Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
 Figure 25. Market Share of Chronic Pain Management Drugs by Player Revenue in 2024
 Figure 26. Top 3 Chronic Pain Management Drugs Players Market Share in 2024
 Figure 27. Top 6 Chronic Pain Management Drugs Players Market Share in 2024
 Figure 28. Global Chronic Pain Management Drugs Consumption Value Share by Type (2020-2025)
 Figure 29. Global Chronic Pain Management Drugs Market Share Forecast by Type (2026-2031)
 Figure 30. Global Chronic Pain Management Drugs Consumption Value Share by Application (2020-2025)
 Figure 31. Global Chronic Pain Management Drugs Market Share Forecast by Application (2026-2031)
 Figure 32. North America Chronic Pain Management Drugs Consumption Value Market Share by Type (2020-2031)
 Figure 33. North America Chronic Pain Management Drugs Consumption Value Market Share by Application (2020-2031)
 Figure 34. North America Chronic Pain Management Drugs Consumption Value Market Share by Country (2020-2031)
 Figure 35. United States Chronic Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 36. Canada Chronic Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 37. Mexico Chronic Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 38. Europe Chronic Pain Management Drugs Consumption Value Market Share by Type (2020-2031)
 Figure 39. Europe Chronic Pain Management Drugs Consumption Value Market Share by Application (2020-2031)
 Figure 40. Europe Chronic Pain Management Drugs Consumption Value Market Share by Country (2020-2031)
 Figure 41. Germany Chronic Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 42. France Chronic Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 43. United Kingdom Chronic Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 44. Russia Chronic Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 45. Italy Chronic Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 46. Asia-Pacific Chronic Pain Management Drugs Consumption Value Market Share by Type (2020-2031)
 Figure 47. Asia-Pacific Chronic Pain Management Drugs Consumption Value Market Share by Application (2020-2031)
 Figure 48. Asia-Pacific Chronic Pain Management Drugs Consumption Value Market Share by Region (2020-2031)
 Figure 49. China Chronic Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 50. Japan Chronic Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 51. South Korea Chronic Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 52. India Chronic Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 53. Southeast Asia Chronic Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 54. Australia Chronic Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 55. South America Chronic Pain Management Drugs Consumption Value Market Share by Type (2020-2031)
 Figure 56. South America Chronic Pain Management Drugs Consumption Value Market Share by Application (2020-2031)
 Figure 57. South America Chronic Pain Management Drugs Consumption Value Market Share by Country (2020-2031)
 Figure 58. Brazil Chronic Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 59. Argentina Chronic Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 60. Middle East & Africa Chronic Pain Management Drugs Consumption Value Market Share by Type (2020-2031)
 Figure 61. Middle East & Africa Chronic Pain Management Drugs Consumption Value Market Share by Application (2020-2031)
 Figure 62. Middle East & Africa Chronic Pain Management Drugs Consumption Value Market Share by Country (2020-2031)
 Figure 63. Turkey Chronic Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 64. Saudi Arabia Chronic Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 65. UAE Chronic Pain Management Drugs Consumption Value (2020-2031) & (USD Million)
 Figure 66. Chronic Pain Management Drugs Market Drivers
 Figure 67. Chronic Pain Management Drugs Market Restraints
 Figure 68. Chronic Pain Management Drugs Market Trends
 Figure 69. Porters Five Forces Analysis
 Figure 70. Chronic Pain Management Drugs Industrial Chain
 Figure 71. Methodology
 Figure 72. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Pfizer Inc.
Depomed Inc.
Endo International plc.
Purdue Pharma L.P.
Novartis AG
AstraZeneca plc.
Johnson and Johnson Services Inc.
Merck & Co.
Abbott Laboratories
GlaxoSmithKline plc.
Teva Pharmaceutical Industries Ltd.

Related Reports

Global Chronic Pain Management Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Chronic Pain Management Drugs Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 27 Feb 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Chronic Pain Management Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Chronic Pain Management Drugs Supply, Demand and Key Producers, 2023-2029

Global Chronic Pain Management Drugs Supply, Demand and Key Producers, 2023-2029

date 23 Mar 2023

date Pharma & Healthcare

The global Chronic Pain Management Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Chronic Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Chronic Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 26 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Chronic Pain Management Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Chronic Pain Management Drugs

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>